Researchers at Cedars-Sinai Medical Center recently discovered that a combination of enzalutamide and hormone therapy could cut the risk of death from prostate cancer by 40%. The clinical trial ...

Project Title: “SDTM Conversion and Standardisation of Hypertension Study Data – Valsartan Hydrochlorothiazide.” Project Description: As part of my SAS training, I worked on converting raw clinical ...